Get the full picture
Sign in to uncover key details.
Adecto Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
75 Kneeland St Fl 14, Boston, Massachuse...Phone Number
(617) 903-8364Website
www.adectopharma.comRevenue
<$5 MillionIndustry
About Adecto Pharmaceuticals
Adecto Pharmaceuticals is a pre-clinical stage therapeutic company focused on developing targeted treatments for aggressive ADAM8-positive cancers, along with a companion diagnostic to identify suitable patients. With over 30 years of research, the company aims to halt both primary cancer growth and metastasis. Their initial focus is on breast cancer, with plans to expand into other oncology indications. An estimated 2 million patients globally could benefit from their innovative products.Explore more
Adecto Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Adecto Pharmaceuticals
Compare insights from companies similar to Adecto Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Adecto Pharmaceuticals Tech Stack
A closer look at the technologies used by Adecto Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adecto Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Adecto Pharmaceuticals is a pre-clinical stage therapeutic company focused on developing targeted treatments for aggressive ADAM8-positive cancers, along with a companion diagnostic to identify suitable patients. With over 30 years of research, the company aims to halt both primary cancer growth and metastasis. Their initial focus is on breast canc... Read More
